-+ 0.00%
-+ 0.00%
-+ 0.00%

Yipinhong announced that the company's wholly-owned subsidiaries Yipinhong Pharmaceuticals and Lianrui Pharmaceuticals participated in the 12th batch of centralized procurement of national drugs on July 31, 2026. They plan to win the bid for injectable isaconazole sulfate and perindopril amlodipine tablets. Perindopril amlodipine tablets had a sales revenue of 3.4817 million yuan in 2025, accounting for 0.37% of the company's 2025 revenue. The procurement period starts on the date of execution of the selected results and ends on December 31, 2029.

Zhitongcaijing·08/03/2026 03:49:01
Listen to the news
Yipinhong announced that the company's wholly-owned subsidiaries Yipinhong Pharmaceuticals and Lianrui Pharmaceuticals participated in the 12th batch of centralized procurement of national drugs on July 31, 2026. They plan to win the bid for injectable isaconazole sulfate and perindopril amlodipine tablets. Perindopril amlodipine tablets had a sales revenue of 3.4817 million yuan in 2025, accounting for 0.37% of the company's 2025 revenue. The procurement period starts on the date of execution of the selected results and ends on December 31, 2029.